Bodhi Tree Biotechnology Inc (BDTB) EBITDA Margin (2024 - 2026)

Bodhi Tree Biotechnology (BDTB) has reported EBITDA Margin for 3 consecutive years, with 231.95% the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBITDA Margin changed N/A year-over-year to 231.95% in Q2 2026; TTM through Jun 2026 was 485.48%, a N/A change from a year earlier, with the FY2025 full-year figure at 868.34%, down 69133.0% from the prior year.
• EBITDA Margin was 231.95% for Q2 2026 at Bodhi Tree Biotechnology, down from 89.06% in the prior quarter.
• Over five years, EBITDA Margin peaked at 89.06% in Q3 2025 and troughed at 1295.54% in Q4 2024.
• A 3-year average of 538.85% and a median of 231.95% in 2026 frame the typical range for EBITDA Margin.